Jong Hwa J. Joo

Jong Hwa J. Joo


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
JJJunghyun Jung
Junghyun Jung
GKGo Woon Kim
Go Woon Kim
BLByungjo Lee
Byungjo Lee
JJJong Hwa J. Joo
Jong Hwa J. Joo
WJWonhee Jang
Wonhee Jang
Dupuytren’s disease (DD) is a fibroproliferative disorder characterized by thickening and contracting palmar fascia. The exact pathogenesis of DD remains unknown. In this study, we identified co-expressed gene set (DD signature) consisting of 753 genes via weighted gene co-expression network analysis. To confirm the robustness of DD signature, module enrichment analysis and meta-analysis were performed. Moreover, this signature effectively classified DD disease samples. The DD signature were significantly enriched in unfolded protein response (UPR) related to endoplasmic reticulum (ER) stress. Next, we conducted multiple-phenotype regression analysis to identify trans-regulatory hotspots regulating expression levels of DD signature using Genotype-Tissue Expression data. Finally, 10 trans-regulatory hotspots and 16 eGenes genes that are significantly associated with at least one cis-eQTL were identified. Among these eGenes, major histocompatibility complex class II genes and ZFP57 zinc finger protein were closely related to ER stress and UPR, suggesting that these genetic markers might be potential therapeutic targets for DD.

30 October 2019 in Genes
Verified
Journal Article
Open access
PDF file
JSJaeseung Song
Jaeseung Song
DKDaeun Kim
Daeun Kim
JHJuyeon Hong
Juyeon Hong
GKGo Woon Kim
Go Woon Kim
JJJunghyun Jung
Junghyun Jung
WJWonhee Jang
Wonhee Jang
Polymyositis (PM) and dermatomyositis (DM) are both classified as idiopathic inflammatory myopathies. They share a few common characteristics such as inflammation and muscle weakness. Previous studies have indicated that these diseases present aspects of an auto-immune disorder; however, their exact pathogenesis is still unclear. In this study, three gene expression datasets (PM: 7, DM: 50, Control: 13) available in public databases were used to conduct meta-analysis. We then conducted expression quantitative trait loci analysis to detect the variant sites that may contribute to the pathogenesis of PM and DM. Six-hundred differentially expressed genes were identified in the meta-analysis (false discovery rate (FDR) < 0.01), among which 317 genes were up-regulated and 283 were down-regulated in the disease group compared with those in the healthy control group. The up-regulated genes were significantly enriched in interferon-signaling pathways in protein secretion, and/or in unfolded-protein response. We detected 10 single nucleotide polymorphisms (SNPs) which could potentially play key roles in driving the PM and DM. Along with previously reported genes, we identified 4 novel genes and 10 SNP-variant regions which could be used as candidates for potential drug targets or biomarkers for PM and DM.

18 November 2020 in BMC Genomics
Verified
Journal Article
Open access
PDF file
JCJu Hun Choi
Ju Hun Choi
TKTaegun Kim
Taegun Kim
JJJunghyun Jung
Junghyun Jung
JJJong Hwa J. Joo
Jong Hwa J. Joo
Background: Regulatory hotspots are genetic variations that may regulate the expression levels of many genes. It has been of great interest to find those hotspots utilizing expression quantitative trait locus (eQTL) analysis. However, it has been reported that many of the findings are spurious hotspots induced by various unknown confounding factors. Recently, methods utilizing complicated statistical models have been developed that successfully identify genuine hotspots. Next-generation Intersample Correlation Emended (NICE) is one of the methods that show high sensitivity and low false-discovery rate in finding regulatory hotspots. Even though the methods successfully find genuine hotspots, they have not been widely used due to their non-user-friendly interfaces and complex running processes. Furthermore, most of the methods are impractical due to their prohibitively high computational complexity. Results: To overcome the limitations of existing methods, we developed a fully automated web-based tool, referred to as NICER (NICE Renew), which is based on NICE program. First, we dramatically reduced running and installing burden of NICE. Second, we significantly reduced running time by incorporating multi-processing. Third, besides our web-based NICER, users can use NICER on Google Compute Engine and can readily install and run the NICER web service on their local computers. Finally, we provide different input formats and visualizations tools to show results. Utilizing a yeast dataset, we show that NICER can be successfully used in an eQTL analysis to identify many genuine regulatory hotspots, for which more than half of the hotspots were previously reported elsewhere. Conclusions: Even though many hotspot analysis tools have been proposed, they have not been widely used for many practical reasons. NICER is a fully-automated web-based solution for eQTL mapping and regulatory hotspots analysis. NICER provides a user-friendly interface and has made hotspot analysis more viable by reducing the running time significantly. We believe that NICER will become the method of choice for increasing power of eQTL hotspot analysis.

17 December 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
FHFarhad I Hormozdiari
Farhad I Hormozdiari
JJJunghyun Jung
Junghyun Jung
EEEleazar Eskin
Eleazar Eskin
JJJong Hwa J. Joo
Jong Hwa J. Joo
The standard genome-wide association studies (GWAS) detects an association between a single variant and a phenotype of interest. Recently, several studies reported that at many risk loci, there may exist multiple causal variants. For a locus with multiple causal variants with small effect sizes, the standard association test is underpowered to detect the associations. Alternatively, an approach considering effects of multiple variants simultaneously may increase statistical power by leveraging effects of multiple causal variants. In this paper, we propose a new statistical method, Model-based Association test Reflecting causal Status (MARS), that tries to find an association between variants in risk loci and a phenotype, considering the causal status of the variants. One of the main advantages of MARS is that it only requires the existing summary statistics to detect associated risk loci. Thus, MARS is applicable to any association study with summary statistics, even though individual level data is not available for the study. Utilizing extensive simulated data sets, we show that MARS increases the power of detecting true associated risk loci compared to previous approaches that consider multiple variants, while robustly controls the type I error. Applied to data of 44 tissues provided by the Genotype-Tissue Expression (GTEx) consortium, we show that MARS identifies more eGenes compared to previous approaches in most of the tissues; e.g. MARS identified 16% more eGenes than the ones reported by the GTEx consortium. Moreover, applied to Northern Finland Birth Cohort (NFBC) data, we demonstrate that MARS effectively identifies association loci with improved power (56% of more loci found by MARS) inGWAS studies compared to the standard association test.

30 September 2020 in International Journal of Fuzzy Logic and Intelligent Systems
Verified
Journal Article
Open access
PDF file
GLGi Ju Lee
Gi Ju Lee
SPSung Min Park
Sung Min Park
JJJumghyun Jun
Jumghyun Jun
JJJong Hwa J. Joo
Jong Hwa J. Joo
Gi Ju Lee, Sung Min Park, Junghyun Jung, and Jong Wha J. Joo. IJFIS 2020;20:219-26. https://doi.org/10.5391/IJFIS.2020.20.3.219